Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$1024.09 - $1201.76 $8,192 - $9,614
-8 Reduced 2.1%
373 $392,000
Q2 2024

Jul 29, 2024

BUY
$883.2 - $1071.19 $4,416 - $5,355
5 Added 1.33%
381 $400,000
Q1 2024

May 14, 2024

SELL
$902.69 - $993.35 $28,886 - $31,787
-32 Reduced 7.84%
376 $361,000
Q4 2023

Feb 14, 2024

BUY
$775.18 - $881.7 $97,672 - $111,094
126 Added 44.68%
408 $358,000
Q3 2023

Nov 13, 2023

BUY
$692.45 - $844.37 $195,270 - $238,112
282 New
282 $232,000
Q1 2023

Apr 28, 2023

SELL
$680.49 - $826.97 $16,331 - $19,847
-24 Reduced 8.22%
268 $220,000
Q4 2022

Feb 10, 2023

SELL
$705.89 - $766.39 $4,235 - $4,598
-6 Reduced 2.01%
292 $210,000
Q3 2022

Nov 14, 2022

BUY
$573.97 - $724.32 $171,043 - $215,847
298 New
298 $205,000
Q2 2022

Aug 10, 2022

SELL
$548.35 - $738.84 $228,113 - $307,357
-416 Closed
0 $0
Q1 2022

May 04, 2022

BUY
$595.12 - $698.43 $51,180 - $60,064
86 Added 26.06%
416 $291,000
Q4 2021

Feb 07, 2022

BUY
$543.48 - $670.97 $179,348 - $221,420
330 New
330 $208,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $72.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Ameritas Advisory Services, LLC Portfolio

Follow Ameritas Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Advisory Services, LLC with notifications on news.